Table 2 Quantitative assessment of transitivity for mean age and gender of trial participants
Comparison | RCTs | Participants | Age, years | Females, % | ||
|---|---|---|---|---|---|---|
Mean (SD) | Difference | Included | Difference | |||
Davey 2021 | ||||||
HA:NOP | 2 | 105 | 77.4 (NA) | reference | 90 | reference |
LCP:HA | 1 | 32 | 71.6 (NA) | −5.7 | 84 | −6 (ns) |
LCP:IMN | 3 | 184 | 65.0 (NA) | −12.3 | 72 | − 18 (*) |
LCP:NOP | 3 | 197 | 73.0 (NA) | −4.4 | 87 | −3 (ns) |
LCP:RSA | 1 | 124 | 75.2 (6.4) | −2.2 | 90 | 0 (ns) |
RSA:HA | 1 | 61 | 74.0 (NA) | −3.4 | 85 | −5 (ns) |
RSA:NOP | 1 | 59 | 83.5 (5.1) | 6.2 | 86 | −4 (ns) |
Du 2017 | ||||||
HA:NOP | 2 | 105 | 77.4 (NA) | reference | 90 | reference |
ORIF:HA | 1 | 32 | 71.6 (NA) | −5.7 | 84 | −6 (ns) |
ORIF:NOP | 3 | 149 | 73.5 (NA) | −3.9 | 85 | −5 (ns) |
RSA:HA | 1 | 61 | 74.0 (NA) | −3.4 | 85 | −5 (ns) |
Orman 2020 | ||||||
HA:NOP | 2 | 105 | 77.4 (NA) | reference | 90 | reference |
ORIF:HA | 2 | 92 | 68.0 (NA) | −9.4 | 64 | −26 (*) |
ORIF:NOP | 3 | 149 | 73.5 (NA) | −3.9 | 85 | −5 (ns) |
RSA:HA | 1 | 61 | 74.0 (NA) | −3.4 | 85 | −5 (ns) |